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A hallmark of skeletal muscle cells is the
position of nuclei at the cell periphery.
Roman et al. show that myofibroblasts
deposit extracellular components—
fibronectin—at the surface of developing
muscle cells to locally attract myonuclei
to the cell periphery.
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Skeletal muscle cells (myofibers) are rod-shaped
multinucleated cells surrounded by an extracellular
matrix (ECM) basal lamina. In contrast to other cell
types, nuclei in myofibers are positioned just below
the plasma membrane at the cell periphery. Periph-
eral nuclear positioning occurs during myogenesis
and is driven by myofibril crosslinking and contrac-
tion. Here we show that peripheral nuclear posi-
tioning is triggered by local accumulation of fibro-
nectin secreted by myofibroblasts. We demonstrate
that fibronectin via a5-integrin mediates peripheral
nuclear positioning dependent on FAK and Src acti-
vation. Finally, we show that Cdc42, downstream of
restricted fibronectin activation, is required for
myofibril crosslinking but not myofibril contraction.
Thus we identify that local activation of integrin by
fibronectin secreted by myofibroblasts activates
peripheral nuclear positioning in skeletal myofibers.
INTRODUCTION
Skeletal muscle is a mechanical system designed to generate
force for locomotion and posture. Several cell types participate
in the tissue’s development, regeneration, and homeostasis to
endure stress and strain from muscle usage. Muscle cells (myo-
fibers) responsible for contraction are multinucleated and rod-
shaped with the particularity of having their nuclei positioned at
the periphery, in close contact with the plasma membrane (Ca-
dot et al., 2015). Nuclei are equally distributed in fully matured
myofibers apart from specialized regions such as myotendinous
and neuromuscular junctions. It is duringmyogenesis in newborn
mice that nuclei transition from the center to the periphery of the
myofiber due to myofibril crosslinking, myofibril contraction, and
local changes of nuclear stiffness (Harris et al., 1989; Roman
et al., 2017;Wada et al., 2003). Myofibril crosslinking is mediated
by desmin organization at the z lines, which is the downstream
result of a pathway involving N-Wasp, the Arp2/3 complex con-
taining Arpc5L and g-actin. This pathway is disrupted in patients
with BIN1mutations, found in centronuclear myopathies (CNM),102 Developmental Cell 46, 102–111, July 2, 2018 ª 2018 The Autho
This is an open access article under the CC BY-NC-ND license (http://and leads to nuclear-positioning defects (D’Alessandro et al.,
2015; Falcone et al., 2014). How peripheral nuclear positioning
is activated is unknown, but proper positioning of nuclei is impor-
tant for muscle function (Gimpel et al., 2017; Metzger
et al., 2012).
Interaction of myofibers with the extracellular matrix (ECM) is
required for myofiber formation and function. These interactions
are mediated by different adhesion receptors, of which integrins
are one of the main families (Goody et al., 2015). Integrins are
divalent receptors (a and b chains) that bind to ECM proteins
resulting in intracellular signaling cascades that play biological
functions during muscle development, homeostasis, and
regeneration (Campbell and Humphries, 2011). a5b1-integrin is
activated by fibronectin and ismostly expressed during develop-
ment. Whereas a5 knockout mice die prior to muscle formation,
chimeric a5 mice (/; +/+) form myofibers with multiple
defects, including mispositioned nuclei (Taverna et al., 1998).
The importance of a5b1-integrin during development is not
surprising, as fibronectin is the main ECM component surround-
ing myofibers and is laid down by different cell types including
fibroblasts and myofibroblasts (Eyden, 2008; Gulati, 1985; Torr
et al., 2015). Integrins can activate, among other effectors, small
Rho guanosine triphosphatases (GTPases), which are the main
switches regulating the cytoskeleton (Huveneers and Danen,
2009, 2009). There are three classes of small Rho GTPases;
Rho, Rac, and Cdc42 (Heasman and Ridley, 2008; Ridley and
Hodge, 2016). Cdc42 can directly activate N-Wasp to stimulate
actin dynamics (Rohatgi et al., 1999). Here we tested whether
local activation of integrins by fibronectin can activate peripheral
nuclear positioning.RESULTS
Myofibroblasts Trigger Peripheral Nuclear Positioning
in Skeletal Muscle Fibers
To study the mechanisms of skeletal muscle differentiation, we
used an in vitro system in which primarymuscle cells (myoblasts)
isolated from muscle are differentiated into highly matured myo-
fibers with peripheral nuclei (Falcone et al., 2014; Pimentel et al.,
2017). In this system, myoblasts fuse at day 0 forming multinu-
cleated cells that elongate into myotubes with spread and
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Figure 1. Non-muscle Cells Are Involved in Nuclear Movement to the Periphery of Myofibers
(A) Representative transmitted image highlighting the interactions (yellow arrowheads) between non-muscle cells and myofibers at day 2 (no interaction, left) and
day 5 (interactions, right). Bottom panels depict non-muscle cell (blue) and myofiber (dashed red) interaction as outlines from upper panels. Scale bars, 10 mm.
(B) Quantification of number of interactions between myofibers and non-muscle cell during muscle development. Data from three independent experiments with
n = 19 myofibers quantified. Error bars correspond to SEM.
(C) Representative immunofluorescence image of in vitro culture containingmyofibers and non-muscle cells stained either for a-smoothmuscle actin (a-sm-actin,
magenta), desmin (green), and DAPI (nucleus, blue). Scale bar, 10 mm.
(D) Quantification of number of myofibroblasts and other non-muscle cells per mm2, treated with vehicle or mitomycin, during muscle development. Data
collected from three independent experiments with at least 12 areas of 322 mm2 for each condition. Error bars correspond to SEM.
(E) Representative immunofluorescence image of 10-daymyofibers treatedwith vehicle, mitomycin, or mitomycin supplemented with untreated non-muscle cells
and stained for F-actin (myofibrils, green) and DAPI (nucleus, blue). Scale bar, 10 mm.
(F) Quantification of peripheral nuclei in 10-day myofibers treated with vehicle, mitomycin, or mitomycin supplemented with untreated non-muscle cells. Data
from three independent experiments were combined and error bars represent SEM from indicated number of nuclei (n) for each cohort. Unpaired t test was used
to determine statistical significance, where *p < 0.05, ***p < 0.001.myotube around at day 4–5, resulting in the formation of myofib-
ers. Non-muscle cells are also present, as a pure culture of pri-
mary myoblasts is not obtained with this protocol (Falconeet al., 2014; Roman et al., 2017). These cells proliferate and
interact with myotubes with the number of interactions
increasing over time (Figures 1A and 1B). When we normalizedDevelopmental Cell 46, 102–111, July 2, 2018 103
the number of interactions relative to the number of mononucle-
ated cells, we observed an increase of interactions between day
4 and day 6, at the onset of peripheral nuclear movement per
mononucleated cell (Figure S1A).
To better understand the nature of the proliferative mononu-
cleated cell population, we performed immunostainings against
a-smooth muscle actin, CD31, MAP2, and desmin to identify
myofibroblasts, endothelial cells, neuronal cells, and myocytes,
respectively. At day 1, 45% of non-muscle cells (desmin nega-
tive) were positive for a-smooth muscle actin (i.e., myofibro-
blasts), whereas no mononucleated cell was expressing CD31
or MAP2 (Figures 1C and 1D). By day 5, the proportion of myofi-
broblasts increased to 75% of the total mononucleated cell
population, making myofibroblasts the major proliferating cell
type alongside maturing myotubes in vitro (Figure 1D). We also
observed myofibroblasts in between myofibers in muscle of
newborn mice (Figure S1B).
Due to the observed interaction between proliferating myofi-
broblasts and myotubes, we wondered whether the proliferation
of myofibroblasts is involved in myofiber differentiation. To this
end, we treated the in vitro cultures with mitomycin for 2 hr at
day 0 before differentiation, during myoblast fusion. Mitomycin
prevents the proliferation of cells such as undifferentiated
myoblasts and other mononucleated cells without affecting
differentiated myoblasts and myotubes, since these cells are
post-mitotic (Cooper et al., 2004; Falcone et al., 1984; Pajcini
et al., 2008). As expected, mitomycin treatment resulted in a dra-
matic reduction of myofibroblasts in the plate (Figures 1D and
S1C). Bromodeoxyuridine pulse experiments showed that
most of the myoblasts were differentiated at day 0, and upon
mitomycin treatment we observed a minor reduction of undiffer-
entiated myoblasts (Figures S1D and S1E). Myotube formation
and elongation, myofibrillogenesis, and transverse triad forma-
tion were unaffected by mitomycin treatment, indicating that
overall myofiber development was unaltered (Figures 1E, S1F,
and S1G). Strikingly, nuclear movement to the periphery of
myotubes was inhibited in cultures treated with mitomycin
when compared with untreated cultures (Figures 1E and 1F).
To confirm the involvement of non-muscle cells in nuclear posi-
tioning, we tested whether the addition of proliferative non-mus-
cle cells to mitomycin-treated cultures was able to restore
peripheral nuclear positioning. We found that increasing the
number of non-muscle cells leads to an increase in the number
of peripheral nuclei (Figures 1E and 1F), confirming that non-
muscle cells are important for nuclear positioning.
Fibronectin Is Required for Peripheral Nuclear
Positioning in Skeletal Muscle Fibers
Myofibroblasts and fibroblasts secrete fibronectin (Eyden, 2008;
Torr et al., 2015). We therefore validated that at day 5, the fibro-
nectin amount increased when compared with day 2 or cultures
treated with mitomycin (Figure S2A).
We tested whether fibronectin played a role in peripheral
nuclear positioning by adding increasing amounts of fibronectin
to mitomycin-treated myotubes. Fibronectin addition restored
nuclear positioning at the periphery of myofibers to levels similar
to those of untreated cultures (Figures 2A and 2B). We also
purified satellite cells, myoblast precursors, from Pax7-nGFP
mice (Sambasivan et al., 2009) (Figures S2B–S2E) and found104 Developmental Cell 46, 102–111, July 2, 2018that cultures obtained from satellite cells displayed a peripheral
nuclear phenotype similar to that of the mitomycin-treated cul-
tures. We were able to restore peripheral nuclear positioning
by adding fibronectin to these satellite cell-derived cultures (Fig-
ure 2B). Additions of laminin or collagen, other ECM proteins,
were not sufficient to restore peripheral nuclear positioning in
mitomycin-treated cultures (Figure S2F).
To further support the role for fibronectin in peripheral nuclear
positioning, we knocked down fibronectin in our cultures and
observed that peripheral nuclear positioning was also inhibited
(Figures 2C, 2D, and S2G).
We next tested whether fibronectin is locally deposited by
myofibroblasts to promote peripheral nuclear positioning. We
performed live imaging of myofibroblasts overexpressing GFP-
fibronectin at day 4 and observed that myofibroblasts deposit
fibronectin next to myotubes upon interaction (Figure 2E). Using
immunofluorescence microscopy, we also observed extracel-
lular fibronectin bundles touching myofibers at areas with nuclei
(Figure 2F). Together these data suggest that myofibroblasts
locally deposit fibronectin at the surface of myotubes.
We next determined whether local accumulation of fibronectin
is involved in peripheral nuclear positioning. To test this hypoth-
esis, we performed live imaging of myotubes cultured alongside
20-mm polystyrene beads pre-coated with fibronectin, and
observed nuclei migrating toward the bead and then to the
periphery (Figure 3A). We found that peripheral nuclei were local-
ized in proximity to fibronectin-coated beads for 60% of beads
touching myotubes, whereas only 24% of control beads (coated
with bovine serum albumin-BSA) co-localized with peripheral
nuclei (Figures 3B and 3C). Moreover, fibronectin-coated beads
were able to rescue peripheral nuclei in mitomycin-treated cul-
tures (Figures 3D–3F). Overall, these results strongly suggest
that fibronectin can locally trigger peripheral nuclear positioning.
a5-Integrin Is Activated by Fibronectin for Nuclear
Positioning
The main receptor of fibronectin in cells is the integrin family of
divalent receptors composed of an a and a b chain (Campbell
and Humphries, 2011). Within this extensive family, a5b1 is one
of the prevalent fibronectin receptors. We therefore depleted
myotubes of the a5-integrin using small interfering RNA and
observed a decrease in peripheral nuclei with no effect on myofi-
bril formation (Figures 3G, 3H, and S2H). To confirm the involve-
ment of a5-integrin in nuclear movement to the periphery, we
added beads coated with BSA or fibronectin to a5-integrin
knocked-down myotubes and found that neither beads rescued
peripheral nuclear positioning (Figures S2I–S2K). Interestingly,
nuclei still co-localized with fibronectin-coated beads but not
with BSA-coated beads (Figures S2I and S2K), suggesting that
a5-integrin is required for peripheral nuclear positioning down-
stream of fibronectin but that another mechanism involves
attracting nuclei to fibronectin hotspots. We confirmed the acti-
vation of the a5-integrin receptor by performing a 9EG7 (b-integ-
rin) and SNAKA51 (activated a5-integrin) staining (Clark et al.,
2005) and observed co-localization in myofiber nuclei moving
to the periphery (Figure 3I). Co-localization of 9EG7 and
SNAKA51 at fibrillar adhesions was also observed in myofibro-
blasts, as previously described in human and mouse cells
(Lagana et al., 2006). Enrichment of the activated a5-integrin
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Figure 2. Fibronectin Secreted by Myofibroblasts Is Required for Peripheral Nuclear Positioning
(A) Representative immunofluorescence image of 10-daymyofibers treated with vehicle, mitomycin, or mitomycin supplemented with fibronectin, and stained for
F-actin (myofibrils, green) and DAPI (nucleus, blue). Scale bar, 10 mm.
(B) Quantification of peripheral nuclei in 10-day myofibers treated with vehicle, mitomycin, or mitomycin supplemented with fibronectin or Pax7 sorted cells
(satellite cells) supplemented or not with fibronectin. Data from three independent experiments were combined and error bars represent SEM from indicated
number of nuclei (n) for each cohort. Unpaired t test was used to determine statistical significance, where *p < 0.05, ***p < 0.001.
(C) Representative immunofluorescence image of 10-day myofibers knocked down for scrambled or fibronectin and stained for F-actin (myofibrils, green),
fibronectin (magenta), and DAPI (nucleus, blue). Scale bar, 10 mm.
(D) Quantification of peripheral nuclei in 10-day myofibers from a culture knocked down for scrambled or fibronectin. Data from three independent experiments
were combined and error bars represent SEM from indicated number of nuclei (n) for each cohort. Unpaired t test was used to determine statistical significance,
where ***p < 0.001.
(E) Time-lapse (hr:min) transmitted light images of myofibroblasts transfected with GFP-fibronectin (green) locally depositing fibronectin on myofiber surface.
Right-hand panels depict myofibroblast (blue), myofiber (dashed red), and fibronectin (black) interaction as outlines from the panels on the left. Scale bar, 10 mm.
(F) Representative immunofluorescence z-projection images of a 5-day myofiber and myofibroblast stained for F-actin (green), fibronectin (magenta), and DAPI
(nucleus, blue). Yellow boxes represent 33magnifications to highlight nuclei positioned at the periphery of the myofiber (1. nucleus is on the left; 2, nucleus is on
the top). Scale bar, 10 mm.
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was also observed at the site of nuclear movement to the periph-
ery in vivo using isolated myofibers from newborn mice
(Figure 3J).
Integrin activation recruits and activates FAK and Src family
kinases by phosphorylation (Huveneers and Danen, 2009). The
FAK-Src complex phosphorylates paxillin, which then recruits
b-Pix to activate Cdc42 (Osmani et al., 2006). We used specific
inhibitors of Src family kinases (PPI) and FAK to test their role
on peripheral nuclear positioning (Hanke et al., 1996; Slack-
Davis et al., 2007). Upon incubation with the inhibitors at day
4.5, we found that peripheral nuclear positioning was inhibited
(Figure 4A). Surprisingly, transverse triad formation was not
inhibited upon Src and FAK inhibition, suggesting a specific
role for these proteins on nuclear positioning and not on trans-
verse triad formation and development (Figure S3A).
Cdc42, but Not Rho and Rac, Is Involved in Peripheral
Nuclear Positioning by Regulating Desmin Crosslinking
Fak and Src family kinases are known mediators of integrin
signaling that activate small Rho GTPases (Rho, Rac, and
Cdc42) (Huveneers and Danen, 2009; Osmani et al., 2006). We
thus used inhibitors of Rho kinase, activated by Rho (Y-27632),
Rac1 (NSC23766), and Cdc42 (ML141) (Gao et al., 2004; Survi-
ladze et al., 2010; Uehata et al., 1997), to study the role of small
Rho GTPases on localization of peripheral nuclei. We found that
inhibition of Rho kinase with Y-27632 did not inhibit peripheral
nuclear positioning or transverse triad formation (Figures 4B,
4C, and S3A). To validate that Y-27632 was inhibiting Rho kinase
under our culture conditions, we confirmed the reduction of actin
stress fibers in cells treated with Y-27632 when compared with
vehicle-treated cells, as previously described (Figure S3B)
(Uehata et al., 1997). On the other hand, treatment of cells with
Rac1 inhibitor inhibited peripheral nuclear positioning, trans-
verse triad formation, and myofibrillogenesis, suggesting an
overall arrest in myotube development (Figures 4B, 4C, andFigure 3. Local Accumulation of Fibronectin Triggers Peripheral Nucle
(A) Time-lapse (hr:min) images of myofiber cultures (transmitted) 20-mm beads c
(yellow arrowhead) moves toward the bead and to the periphery once it reaches
(B) Representative immunofluorescence z-projection images of 10-day myofibers
and stained for F-actin (myofibrils, green) and DAPI (nucleus, blue). Scale bar, 10
(C) Quantification of number of nuclei from 10-day myofibers in proximity to BSA
combined and error bars represent SEM from indicated number of nuclei (n) for ea
***p < 0.001.
(D) Representative immunofluorescence z-projection images of 10-day myofibers
or fibronectin and stained for F-actin (myofibrils, green) and DAPI (nucleus, blue
(E) Quantification of number of peripheral nuclei from 10-day myofibers treated w
three independent experiments were combined and error bars represent SEM fro
determine statistical significance, where **p < 0.01.
(F) Quantification of number of nuclei from 10-day myofibers treated with mitom
pendent experiments were combined and error bars represent SEM from indicat
statistical significance, where *p < 0.05.
(G) Representative immunofluorescence image of 10-day myofibers knocked do
DAPI (nucleus, blue). Scale bar, 10 mm.
(H) Quantification of peripheral nuclei in 10-day myofibers knocked down for scram
and error bars represent SEM from indicated number of nuclei (n) for each c
***p < 0.001.
(I) Representative immunofluorescence image of 5-day myofibers stained for SN
Yellow arrowhead indicates a5-integrin activation in myofibers whereas yellow a
(J) Representative orthogonal (top) and side (bottom) immunofluorescence image
SNAKA51 (a5-integrin, red), and DAPI (nucleus, blue). Yellow arrowhead indicateS3A). Finally, inhibition of Cdc42 upon incubation with ML141
specifically prevented peripheral nuclear positioning, but not
triad formation, as observed for the inhibition of Fak and Src
family kinases (Figures 4A, 4C, and S3A). In addition, BSA- or
fibronectin-coated beads did not restore peripheral nuclei in
ML141-treated cultures (Figures S2L and S2M). Therefore,
Cdc42 is probably activated downstream of the fibronectin
pathway to specifically regulate peripheral nuclear positioning,
but not transverse triad formation, in skeletal muscle cells.
We previously identified that peripheral nuclear positioning
involves the activation of N-Wasp and requires desmin crosslink-
ing of myofibrils mediated by the Arp2/3 complex and g-actin.
We also found a role for myofibril contraction on peripheral
nuclear positioning, independent of the Arp2/3 complex and
g-actin (Falcone et al., 2014; Roman et al., 2017).
Since N-Wasp is a Cdc42 effector and activates the Arp2/3
complex for actin nucleation (Rohatgi et al., 1999), we hypothe-
sized that Cdc42 is involved in desmin organization. Inhibition of
Cdc42 using ML141 prevented the organization of desmin at the
z lines when compared with control (Figures 4D and 4E). On the
other hand, Rho kinase inhibition with Y-27632 did not have an
effect on desmin organization. We also observed that Rac1 inhi-
bition displayed disorganized desmin probably due to its overall
role on muscle development (Figure 4E). Therefore Cdc42 is
involved in desmin organization, which is required to crosslink
myofibrils.
We next tested whether fibronectin, via integrins upstream of
Cdc42, is also involved in desmin organization. We found that
treatment of cultures with mitomycin, a condition in which
peripheral nuclear positioning is inhibited (Figure 2B), prevented
desmin organization (Figure 4F). The addition of fibronectin
restored desmin organization whereas knockdown of fibronectin
or a5-integrin prevented desmin organization (Figure 4F). We
previously demonstrated that myofibril contraction is also
required for peripheral nuclear positioning (Roman et al., 2017).ar Positioning via a5-Integrin
oated with fibronectin (fluorescence, red). Note that centrally located nucleus
the bead (orange arrowhead). Scale bar, 10 mm.
cultured with 20-mmbeads coated with either BSA (top) or fibronectin (bottom)
mm.
- or fibronectin-coated beads. Data from three independent experiments were
ch cohort. Unpaired t test was used to determine statistical significance, where
treated with mitomycin and cultured with 20-mmbeads coated with either BSA
). Scale bar, 10 mm.
ith mitomycin and in contact with BSA- or fibronectin-coated beads. Data from
m indicated number of nuclei (n) for each cohort. Unpaired t test was used to
ycin in proximity to BSA- or fibronectin-coated beads. Data from three inde-
ed number of nuclei (n) for each cohort. Unpaired t test was used to determine
wn for scrambled or a5-integrin and stained for F-actin (myofibrils, green) and
bled or a5-integrin. Data from three independent experiments were combined
ohort. Unpaired t test was used to determine statistical significance, where
AKA51 (a5-integrin, red), 9EG7 (b-integrin, green), and DAPI (nucleus, blue).
sterisk indicates fibrillar adhesions in myofibroblasts. Scale bar, 10 mm.
of isolated myofibers from newborn mice stained for F-actin (myofibrils, green),
s a5-integrin accumulation. Scale bar, 10 mm.


















































































































































































Figure 4. Cdc42 Downstream of Fibronectin
and Integrin Activation Is Required to Orga-
nize Desmin in Myofibers
(A) Quantification of peripheral nuclei in 10-day
myofibers treated with vehicle, PPi (Src inhibitor),
or FAK inhibitor. Data from three independent ex-
periments were combined and error bars represent
SEM from indicated number of nuclei (n) for each
cohort. Unpaired t test was used to determine
statistical significance, where ***p < 0.001.
(B) Representative immunofluorescence image of
10-day myofibers treated with vehicle, Cdc42
inhibitor (ML141), Rac1 inhibitor, or Rock inhibitor
(Y-27632) and stained for F-actin (myofibrils, green)
and DAPI (nucleus, blue). Scale bar, 10 mm.
(C) Quantification of peripheral nuclei in 10-day
myofibers treated with vehicle, ML141, Rac1 in-
hibitor, or Y-27632. Data from three independent
experiments were combined and error bars repre-
sent SEM from indicated number of nuclei (n) for
each cohort. Unpaired t test was used to determine
statistical significance, where ***p < 0.001.
(D) Representative immunofluorescence image of
10-day myofibers treated with vehicle or ML141
and stained for F-actin (myofibrils, green), desmin
(magenta), and DAPI (nucleus, blue). Scale bar,
10 mm.
(E and F) Quantification of transverse desmin
organization in 10-day myofibers from cultures
treated with and knocked down for indicated
conditions. Data from three independent experi-
ments were combined and error bars represent
SEM from at least 30 myofibers for each cohort.
Unpaired t test was used to determine statistical
significance, where *p < 0.05, **p < 0.01,
***p < 0.001.We therefore measured optogenetically induced contractions in
myotubes treated with vehicle, mitomycin, ML141, or depleted
for a5-integrin and found that myofibril contraction was not
impaired since all the cohorts contracted and fatigue experi-
ments revealed no difference of contractile capacity (Figures
S3C and S3D). Furthermore, the increase in calcium concentra-
tion upon contraction was measured with GCaMP6f genetically
encoded sensor and was not affected by the inhibition of
Cdc42 (Figures S3E and S3F). These data rule out a role for
the fibronectin pathway in myofibril contraction. Overall, these
results suggest that the fibronectin-Cdc42 pathway locally con-
trols nuclear movement to the periphery by organizing desmin,
thereby inducing myofibril crosslinking.
DISCUSSION
Peripheral nuclear positioning in myofibers is a hallmark of
muscle formation. Here we show that peripheral nuclear posi-108 Developmental Cell 46, 102–111, July 2, 2018tioning in skeletal muscle fiber is locally
activated by fibronectin via a5-integrin,
FAK, and Src, upstream of Cdc42.
Furthermore, we show that Cdc42 is
involved in desmin crosslinking of myofi-
brils, required for peripheral nuclear
positioning (Figure S4).During myofiber regeneration, fibroblasts and myofibroblasts
have been shown to produce fibronectin to form the ECM and
the basal lamina, and to be required for proper propagation of
muscle precursor cells during regeneration upon injury (Murphy
et al., 2011). Furthermore, fibronectin has also been implicated in
age-dependent muscle regeneration by the activation of integrin
signaling via p38 and ERK/MAPK in muscle precursor cells (Luk-
janenko et al., 2016). We now demonstrate that fibronectin
secreted by myofibroblasts also has a direct role on myofiber
differentiation by locally activating integrin via FAK, Src, and
the small GTPase Cdc42. Cdc42 can then activate myofibril
crosslinking via its effector N-Wasp, leading to desmin remodel-
ing required for peripheral nuclear movement (Falcone et al.,
2014; Roman et al., 2017). It would be interesting in the future
to determine whether integrin signaling in muscle precursor cells
also leads to small GTPase activation and cytoskeleton remod-
eling, as we demonstrated for myofibers (Lukjanenko et al.,
2016; Roman et al., 2017).
Our results also support a restricted role for fibronectin on pe-
ripheral nuclear positioning. In myofibers, peripheral nuclei are
distributed at the periphery to maximize the area of influence
of each nucleus (Bruusgaard et al., 2006). However, some of
these nuclei are specifically clustered at the neuromuscular junc-
tion and are also found along the blood vessels (Ralston et al.,
2006; Sanes and Lichtman, 2001). Fibronectin is known to accu-
mulate at the neuromuscular junction and in the basal membrane
secreted by endothelial cells, in addition to myofibroblasts (Dar-
amola et al., 1997; Sanes, 2003). Therefore the mechanism
described here can also be involved in the positioning of the
nucleus at the neuromuscular junction and near the blood ves-
sels that surround myofibers. The position of nuclei in these
specialized regions could be essential for cell-cell communica-
tion and collective cellular behavior at the tissue level.
Upon reaching the myofiber periphery, nuclei still move longi-
tudinally, although to a much smaller extent than when nuclei are
still in the center of the myotube (Englander and Rubin, 1987;
Falcone et al., 2014; Gache et al., 2017). How peripheral nuclear
movement along the myofiber occurs is unknown. It will there-
fore be important to determine how these unknownmechanisms
driving nuclear movement crosstalk with local fibronectin-trig-
gered signaling.
Small GTPases are master regulators of the cytoskeleton, and
Cdc42 in particular has been associated with the establishment
and control of cell polarity (Etienne-Manneville, 2004). Cdc42
has also been implicated in nuclear positioning during cell migra-
tion via nucleus-cytoskeleton connections, probably activated
by integrin signaling, leading to cell polarization (Etienne-Manne-
ville and Hall, 2001; Gomes et al., 2005; Luxton et al., 2010). The
pathway andmechanismwe describe here shows that local acti-
vation of integrin inmyofibers via specific secretion of fibronectin
by myofibroblasts can locally trigger nuclear positioning. During
cell migration, similar local and specific integrin activation re-
mains to be determined.
The nucleus is positioned within cells taking into account tis-
sue architecture and asymmetry (Gundersen and Worman,
2013). Here we describe that local remodeling of fibronectin-
containing ECM bymyofibroblasts can directly stimulate nuclear
movement and positioning toward the site of ECM remodeling.
We thus propose a mechanism by which cells can sense tissue
architecture and regulate nuclear positioning in accordance
with a local cue established by fibronectin-secreting cells. Future
work should address whether the mechanism we describe here-
in also takes place in other nuclear-positioning events that occur
during development and tissue homeostasis.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Primary Myoblasts and Mouse Strains
C57BL/6 wild type and Pax7-nGFP mice were previously described (Sambasivan et al., 2009). Briefly, a BAC containing approxi-
mately 200 kbp of mouse genomic DNA including the locus encoding Pax7 and sequences both upstream (B12; 55 kbp with
respect to Pax7 initiator ATG) and downstream (60 kbp from terminator codon) on a pBeloBac11 backbone was isolated from a
library (129Sv; CITBCJ7-B; Research Genetics; courtesy ofM. Cohen-Tannoudji). The BACwas then electroporated into E. coli strain
EL 350 and recombinedwith a nuclear localised EGFP (nGFP; frompCIG, courtesy of A.McMahon) as described (Liu et al., 2003). The
targeting vector was designed to introduce nGFP into the first exon of Pax7 gene (mutated initiator ATG and deleted bases 58-94 of
exon 1). Tg: Pax7- nGFP transgenic mice were generated (courtesy of Pasteur Transgenic Platform, F. Langa Vives) bymicroinjection
of fertilized eggs (F1: C57BL6:SJL/J) with the engineered circular BAC. C57BL/6 wild type and Pax7-nGFP mice were kept in a spe-
cific pathogen free (SPF) Mouse Facility and virus antibody free (VAF) Mouse facility, respectively, and were housed in trios (1 male,
two females) for breeding purposes and pups were maintained in the breeding cage until usage. They were housed in individually
ventilated cageswith standard bedding (corncob) and nesting enrichment (home dome and cotton coccons). Both the animal holding
rooms and cages are kept at specific environmental intervals, according to the applicable legislation. Temperature and relative
humidity levels are recorded on a daily basis. Temperature is kept at the neutral thermal zone (20-24C) and relative humidity is main-
tained in a 50-60% range. The room light cycle is 14h light and 10h dark. The animals have ad libitum access to water supply and
standard laboratory chow diet. All procedures using animals were approved by the Animal Ethics Committee at Instituto deMedicina
Molecular and followed the guidelines of the Decreto-lei n 113/2013, 7 of August which is the national legislation that transposes the
European Directive 2010/63/EU on the protection of animals used for scientific purposes. In vitromyofibers were generated with pri-
mary myoblasts isolated from 5 - 7 day old pups of C57BL/6 or Pax7-nGFPmice (Sambasivan et al., 2009). Mouse hind limbmuscles
tibialis anterior (TA), extensor digitorum longus, medial and lateral gastrocnemius, vastus medialis and lateralis were isolated by
severing the tendons using surgical scissors and tweezers. After hind limb muscles isolation, muscles were minced and digestede3 Developmental Cell 46, 102–111.e1–e6, July 2, 2018
for 1.5 h in PBS containing 0.5 mg/ml collagenase (Sigma) and 3.5 mg/ml dispase (Roche) at 37C. Cell suspension was filtered
through a 40-mm cell strainer and preplated in IMDM (Invitrogen) + 10%FBS (Eurobio), to discard the majority of fibroblasts and
contaminating cells, for 4 h in 37C/5%CO2. Non-adherent-myogenic cells were collected and plated in IMDM (Invitrogen) + 20%
FBS + 1% Chick Embryo Extract + 1% Penicillin/streptomycin (Penstrep) onto 1:100 Matrigel Reduced Factor (BD) in IMDM-coated
fluorodishes. Differentiation was triggered by medium switch in IMDM + 2% horse serum + 1%Penstrep, and 24 h later, a thick layer
of matrigel (1:2 in IMDM) was added. Myotubes were treated with 80 mg/ml of agrin and kept in 37C/5%CO2(Falcone et al., 2014).
Due to the difficulty of sexing mouse pups visually, sex of primary myoblasts and isolated myofibers, derived from 5-7 or 0 day old
pups respectively, was not determined.
METHOD DETAILS
Antibodies
The following primary antibodies were used for immunofluorescence and immunohistochemistry: Rabbit anti-a-smooth muscle
actin, mouse anti-Desmin, rabbit anti-Fibronectin, goat anti-CD31, mouse anti-MAP2, rabbit anti-Triadin antibody was a kind gift
from Isabelle Marty, mouse anti-MyoD, rabbit anti-BrdU, mouse anti- Integrin a5 (clone SNAKA51), rat anti- Integrin b1 (clone
9EG7), goat anti- Tensin. Details of secondary antibodies are in the Key Resources Table.
siRNA/cDNA Transfection
Cells were transfected with siRNA (20nM) using RNAiMAX and cDNA (1mg/ml) using Lipofectamine 3000. To transfect, a mix contain-
ing siRNA (20nM) with 1ml RNAiMAX or cDNA (1mg/ml) with 1ml of Lipofectamine 3000 and reagent in 50ml of Opti-MEM was added to
each fluorodish for 30 minutes followed by 1 wash with IMDM + 2% horse serum + 1% Penstrep and medium switch in the same
medium to trigger differentiation. Co-transfections of plasmids and siRNAs were done using Lipofectamine 3000 using the same
protocol. Primary myoblasts were transfected 6 h prior to differentiation in order to promote protein silencing or overexpression
effectiveness from the beginning of differentiation. The following siRNAs were used: Scrambled siRNA, Itga5 siRNA#1, Itga5
siRNA#2, Fn1 siRNA#1 and Fn1 siRNA#2. The following plasmids were used: GFP-fibronectin, ChR2-GFP and GCaMP6f.
Drug Assays
When indicated, cells were treated with Mitomycin (Mitomycin C, 5ng/ml Sigma-Aldrich) 2 hours prior to differentiation. Fibronectin
(1, 5 and 10mg/ml Sigma-Aldrich), Laminin (10mg/ml Sigma-Aldrich), Collagen (10mg/ml Ibidi) and Cilengitide (10mM Sigma-Aldrich)
were added 1 day before myonuclei start positioning at the periphery. ML141 (Cdc42 inhibitor, 10 mM, Sigma-Aldrich), Rac1 inhibitor
(10 mM, Merck Millipore), Y-27632 (ROCK inhibitor, 5 mM, Merck Millipore), FAK inhibitor (1 mM, Sigma-Aldrich) and Src inhibitor,PPi
(10 mM, Merck Millipore) were added 1 day before myonuclei start positioning at the periphery of myofibers.
qPCR
Total RNA was extracted from cultures at day two of differentiation using RNeasy micro kit (Qiagen) according to the manufacturer’s
instructions. RNA yield and purity was assessed using Nanodrop 2000 apparatus. cDNA was synthesized using the High capacity
RNA-to-cDNA kit (Applied Biosystems) following manufacturer instructions.
Quantitative real-time PCR (qPCR) was performed using Power SYBR Green PCR MasterMix (Alfagene) and primers forward and
reverse (Sigma-Aldrich) diluted 1:200 from the initial concentration of 100mM. A mix containing 1 ml primer mix, 4 ml of cDNA and 5 ml
SYBRGreenwasadded to eachwell. Amplification of the Itga5mRNA, encodinga5-integrinwasachievedusing the followingprimers:
Forward primer; 5’-AAAGGACCCACAGAATGACCC-3’, Reverse primer; 5’-CCAAAATCTGAGCGGCAAGG-3’. Fn1mRNA, encoding
fibronectin was amplified using the following primers: Forward primer; 5’-TGACTGGCCTTACCAGAGGG-3’, Reverse primer;
5’-CATCTGTAGGCTGGTTCAGGC-3’. As a control, housekeeping gene mRNA hprt was amplified using the following primers:
Forward primer; 5’-GTTAAGCAGTACAGCCCCAAA-3’, Reverse primer; 5’-AGGGCATATCCAACAACAAACTT-3’. qPCRs were
performed three times and relative transcription levels were determined using the DDct method.
Immunofluorescence and Immunohistochemistry
Fluorodishes were fixed in 4% paraformaldehyde for 10 min, permeabilized with triton X-100 (0.5% in PBS) at room temperature and
washed 3 times with PBS. Cells were blocked with BSA 1% and goat serum 10% for 30 min at room temperature and primary an-
tibodies were incubated overnight at 4C in saponin 0.1% and BSA 1% in PBS. Fluorodishes or isolated fibers were washed 3 times
and then incubated with secondary antibodies together with Phalloidin and DAPI for 60 minutes at room temperature and then
mounted in Fluoromount G. Each experiment was performed at least 3 times.
In Vitro Myofibers Obtained from Satellite Cells
Satellite cells were isolated from Pax7-nGFP mice (Sambasivan et al., 2009)using the previously described protocol (Falcone et al.,
2014). Fluorescence activated cell sorting (FACS) was performed in a FACSAria III based on GFP fluorescence, with the sorted cell
population presenting an average purity of 96,6%. GFP positive cells were plated in 8 well dishes and fibronectin (5mg/ml Sigma-
Aldrich) was added 1 day before myonuclei start positioning at the periphery. Immunofluorescence and peripheral nuclei
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Proliferative Cell Labelling and Quantification
Cells were incubated with a 10 mMBrdU labeling solution (abcam) for a duration of 4h at 37C, 1 day after treatment with mitomycin.
Cells were washed 3 times with PBS,fixed in 4% paraformaldehyde for 10 min, permeabilized with triton X-100 (0.5% in PBS) for
20 min and treated with a 4N HCl solution for 20 min. Cells were washed with a Tris 100mM pH=8 solution and the immunofluores-
cence was performed as indicated above in ‘‘Immunofluorescence and immunohistochemistry’’.
Cells were stained for MyoD and BrdU. Images were then acquired at different areas covering a total of ¼ of the surface of the
fluorodish and stitched together using Zen software (Zeiss). Cells were then counted based on their staining and averaged per
experiment.
Isolation of Myofibers
TA single fibers were isolated as described (Falcone et al., 2014). TA muscle was explanted from newborn male or female CD1 mice
and then digested in DMEM containing 0.2% type I collagenase (Sigma) for 2 h at 37C. Mechanical dissociation of fibers was
performed using a thin pasteur pipette and followed under a transilluminating-fluorescent stereomicroscope.
Muscle Clearing and Immunofluorescence
Whole muscles were fixed in 4% paraformaldehyde for 8h, permeabilized with pre-treatment solution (1% triton X-100; 0,5% Tween;
0,25% Nonidet P-40, euromedex; 0,25% sodium deoxycholate, Sigma; 3% BSA; 0,02% sodium azide and 1% urea, Sigma, in PBS)
overnight and blocked with CBB (Cláudio’s blocking buffer, 1% FBS, 3% BSA, 0,5% triton X-100, 0,01% sodium deoxycholate and
0,02% sodium azide in PBS) for 8h, with the blocking solution being changed every 2 hours. Primary antibodies were incubated for
3 days at 4C while shaking. Whole muscles were then washed with PBS for 8 hours, changing PBS every 2 hours, and incubated in
secondary antibodies together with DAPI for 3 days. The immunostaining was fixed with a solution of 4% paraformaldehyde and
0,25% glutaraldehyde (Electron Microscopy Sciences). After immunostaining, whole muscles were placed in a 25%Formamide/
10% Polyethylene glycol (PEG) solution for 8h followed by immersion in a 50%Formamide/20%PEG overnight. Clearing solutions
were prepared according to the described protocol (Kuwajima et al., 2013). Briefly, 50%Formamide/20%PEG solution was made
by mixing formamide 100% with a 40%PEG/H2O mixture (wt/vol) at a ratio of 1:1 (vol/vol). The 25%Formamide/10%PEG solution
was made by mixing formamide 50% with a 20%PEG/H2O mixture (wt/vol) at a ratio of 1:1 (vol/vol). The 50% formamide solution
was made by stirring formamide 100% in H2O. The PEG 40% solution was made by stirring PEG 8000 MW in warm H2O for
30 minutes.
Microscopy
Live imaging was performed using an incubator to maintain cultures at 37C and 5% CO2 (Okolab) and 3 20 0.3 NA PL Fluo dry
objective. Epi-fluorescence images were acquired using a Nikon Ti microscope equipped with a CoolSNAP HQ2 camera (Roper
Scientific), an XY-motorized stage (Nikon), driven by Metamorph (Molecular Devices). Confocal images were acquired using a Zeiss
LSM 710 and Zeiss LSM 880 with a 63x 1.4 NA Plan-Apochromat objective, driven by ZEN 2012 or 2.1 (black) software, respectively.
3D-time-lapse spinning disk microscopy was performed using a Zeiss Cell Observer Spinning Disk system equipped with Z-piezo
(Prior), Spinning Disk CSU-X1M 5000 (Yokogawa), 488nm 561nm and 638nm excitation laser, an incubator to maintain cultures at
37C and 5% CO2 (Pekon), EM-CCD camera Evolve 512 (Photometrics), a 63x 1.4 NA Plan-Apochromat objective, driven by ZEN
software. Fiji was used as an imaging processing software and Adobe illustrator was used to raise figures.
Fatigue Experiments
Myofibers were transfected with the rhodopsin channel GFP-ChR2 and treated with vehicle, mitomycin or ML141 or knocked down
for a5-integrin. Myofibers were then exposed to blue light and time was monitored until myofibers lost the ability to contract.
Calcium Measurements
Myofibers were transfected with the rhodopsin channel GFP-ChR2 and GCaMP6f and were live imaged at day 5 every 10ms with
maximal blue light exposure. Reaching maximal calcium intensity occurred in 90 ms in all conditions. As such, the relative intensity
was measurement in a ROI at 10 ms intervals.
Coated Bead Experiments
500 ml of 10% polystyrene beads (total of 5x107 beads; Phosphorex) were collected in an Eppendorf tube and centrifuged (6000 rpm,
3-5 min) to discard the supernatant. Beads were then washed 3 times in cold PBS and incubated to rock with 50mg/ml fibronectin or
BSA in cold PBS at 4C overnight. The following day, beads were collected by centrifugation (6000 rpm, 3-5 min), supernatant dis-
carded and beads were incubated in 10mg/ml BSA (1ml) at 4C for 3 hours while rocking. Beads were then washed 3 times in cold
PBS and ressuspended in 1.5ml PBS, aliquoted and stored at -20C. 60 000Beadswere then added tomatrigel before differentiation
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QUANTIFICATION AND STATISTICAL ANALYSIS
Peripheral Nuclei Position Quantification
Quantification was performed as previously described (Falcone et al., 2014). Myofibers were stained for DAPI, F-actin and triads and
images in Z-stacks with 0.5 mm interval were acquired with a Zeiss Cell Observer spinning disk microscope with a Plan-Apochromat
63x/1.4 Oil DIC M27 objective. Nuclei extruding the myofiber periphery were scored as peripheral. In coated beads experiment only
nuclei in close vicinity of beads were quantified.
Transversal Triad Quantification
Quantification was performed as previously described (Falcone et al., 2014). Myofibers were stained for DHPR1, triadin and DAPI and
images in Z-stacks with 0.5 mm interval were acquired with a Zeiss Cell Observer spinning disk microscope with a Plan-Apochromat
63x/1.4 Oil DIC M27 objective. Myofibers having more than 50% of triads organized, where DHPR and Triadin were transversally
overlapping, were scored as positive.
Desmin Quantification
Myofibers were stained for desmin and DAPI and images in Z-stacks with 0.5 mm interval were acquired with a Zeiss Cell Observer
spinning disk microscope with a Plan-Apochromat 63x/1.4 Oil DICM27 objective. Myofibers having more than 70% of desmin trans-
versally organized at the Z-lines were scored as positive.
Non-muscle Cell Quantification
Cultures were fixed from day 1 to day 6 and stained for a-smooth muscle actin, F-actin and desmin. Images were then acquired at
different areas covering a total of ¼ of the surface of the fluorodish and stitched together using Zen software (Zeiss). Cells were then
counted based on their staining and averaged per day and experiment.
Cell-Cell Interaction Quantification
Transmitted live imaging of cultures (day 1 – 6) were collected with images every 30 min (the minimum interaction time observed in
trial experiments using images acquired every 5 min). Number of interactions of non-muscle cells with myotubes and myofibers was
counted whenever the plasma membrane of myotubes or myofibers was deformed by a non-muscle cell. This was performed for
each frame and averaged across positions and experiments over 6 days.
Statistics and Reproducibility
Statistical analysis was performed with Graphpad Prism (version 5.0 of GraphPad Software Inc.). Pair wise comparisons were made
with Student’s t-test. In peripheral nuclei positioning analysis and in fiber thickness analysis in myofibers, Student’s t-tests were
performed between scramble siRNA and experimental condition. The distribution of data points is expressed as mean ± SEM
from three or more independent experiments. For statistics with an n lower than 10, a statistical power test was performed using
GPower 3.1 based on the statistical test used. Outliers were detected using Gribbs’ test at a P value < 0.05. Variability arises in
the maturity obtained from the in vitro muscle system obtained from primary myoblasts. As such, a minimum of 55% of peripheral
nuclei in the control cohorts were required to consider the experiment. Representative images are from at least 3 experiments.
DATA AND SOFTWARE AVAILABILITY
Source data for figure panels Figures 1B, 1D, 1F, 2B, 2D, 3C, 3E, 3F, 3H, 4A, 4C, 4E, 4F as well as supplementary figure panels Fig-
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